Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: NOVARTIS PHARMACEUTICALS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-10-01 to 2025-09-30
Current total value of award: $3387019.66
Description: LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN